Microbiological replacement associated with recurrent pneumonia during chemotherapy for Hodgkin lymphoma: a case report
Abstract
Background. Persistent or recurrent pneumonia during antimicrobial therapy in patients receiving chemotherapy can be difficult to interpret. It may reflect persistence of the initial pathogen, inadequate antimicrobial exposure, noninfectious mimics, aspiration, superinfection or acquisition of a new respiratory pathogen. We report a case illustrating the clinical importance of repeat microbiological assessment when pneumonia persists or worsens despite apparently appropriate antimicrobial treatment. Case presentation. A man in his 80s with advanced classical Hodgkin lymphoma and chronic obstructive pulmonary disease developed pneumonia during chemotherapy. The initial sputum culture yielded cefepime-susceptible Klebsiella oxytoca. Cefepime produced transient defervescence, but oxygen requirements and radiographic abnormalities persisted, and fever recurred from day 18 with radiographic progression by day 19. Repeat sputum obtained on day 23 subsequently yielded extended-spectrum beta-lactamase-producing Klebsiella pneumoniae resistant to piperacillin/tazobactam and cefepime but susceptible to carbapenems. The isolate showed a positive string test, consistent with a hypermucoviscous phenotype. Doripenem was started after the resistant isolate was reported; however, the patient later developed progressive bilateral pulmonary infiltrates and respiratory failure and died. The interpretation of microbiological replacement remained presumptive because the organisms were recovered…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.